LOUIS SULLY: Open Payments
NPI 1346212966 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 8 payments from 4 companies in 2025. Trend: 2023 $67 · 2024 $74 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 3 | $91 |
| Amgen Inc. | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: TEZSPIRE, DUPIXENT.
Industry payments across NE — which companies pay providers there.
